Tocotrienol-rich fraction from annatto ameliorates expression of lysyl oxidase in human osteoblastic MG-63 cells

References

• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–1733.
   PubMed Web of Science ®Google Scholar
• Grossman JM. Osteoporosis prevention. Curr Opin Rheumatol. 2011;23:203–210.
   PubMed Web of Science ®Google Scholar
• Gourion-Arsiquaud S, Faibish D, Myers E, et al. Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res. 2009;24:1565–1571.
   PubMed Web of Science ®Google Scholar
• Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21:195–214.
   PubMed Web of Science ®Google Scholar
• Saito M, Fujii K, Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in case of hip fracture and controls. Calcif Tissue Int. 2006;79:160–168.
   PubMed Web of Science ®Google Scholar
• Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998;16:387–398.
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Martinez-González J, Raposo B, et al. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res. 2008;79:7–13.
   PubMed Web of Science ®Google Scholar
• Kaneda A, Wakazono K, Tsukamoto T, et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res. 2004;64:6410–6415.
   PubMed Web of Science ®Google Scholar
• Hong HH, Pischon N, Santana RB, et al. A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures. J Cell Physiol. 2004;200:53–62.
   PubMed Web of Science ®Google Scholar
• Pischon N, Darbois LM, Palamakumbura AH, et al. Regulation of collagen deposition and lysyl oxidase by tumor necrosis factor-alpha in osteoblasts. J Biol Chem. 2004;279:30060–30065.
   PubMed Web of Science ®Google Scholar
• Buchinger B, Spitzer S, Karlic H, et al. Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin. Cancer Lett. 2008;265:45–54.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sundaram C, Prasad S, et al. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol. 2010;80:1613–1631.
   PubMed Web of Science ®Google Scholar
• Serbinova E, Kagan V, Han D, et al. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med. 1991;10:263–275.
   PubMed Web of Science ®Google Scholar
• Müller L, Theile K, Böhm V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res. 2010;54:731–742.
   PubMed Web of Science ®Google Scholar
• Miyazawa T, Shibata A, Sookwong P, et al. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). J Nutr Biochem. 2009;20:79–86.
   PubMed Web of Science ®Google Scholar
• Yano T, Sato A, Sekine M, et al. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent. Anticancer Agents Med Chem. 2013;13:496–501.
   PubMed Web of Science ®Google Scholar
• Kannappan R, Gupta SC, Kim JH, et al. Tocotrienols fight cancer by targeting multiple cell signaling pathways. Genes Nutr. 2012;27:43–52.
   Google Scholar
• Chin KY, Ima-Nirwana S. Vitamin E as an antiosteoporotic agent via receptor activator of nuclear factor kappa-B ligand signaling disruption: current evidence and other potential research areas. Evid Based Complement Alternat Med. 2012;2012:747020.
   PubMedGoogle Scholar
• Angeli A, Dovio A, Sartori ML, et al. Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann N Y Acad Sci. 2002;966:97–107.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Bhattacharya S, Braunstein J, et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285:1–24.
   PubMed Web of Science ®Google Scholar
• Thaler R, Agsten M, Spitzer S, et al. Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J Biol Chem. 2011;286:5578–5588.
   PubMed Web of Science ®Google Scholar
• Fernandes H, Dechering K, Van Someren E, et al. The role of collagen crosslinking in differentiation of human mesenchymal stem cells and MC3T3-E1 cells. Tissue Eng Part A. 2009;15:3857–3867.
   PubMed Web of Science ®Google Scholar
• Turecek C, Fratzl-Zelman N, Rumpler M, et al. Collagen cross-linking influences osteoblastic differentiation. Calcif Tissue Int. 2008;82:392–400.
   PubMed Web of Science ®Google Scholar
• Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 2002;59:241–257.
   PubMed Web of Science ®Google Scholar
• Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet. 2009;10:805–811.
   PubMed Web of Science ®Google Scholar
• Okano M, Bell DA, Haber EL. DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257.
   PubMed Web of Science ®Google Scholar
• Chin KY, Abdul-Majeed S, Fozi NF, et al. Annatto tocotrienol improves indices of bone static histomorphometry in osteoporosis due to testosterone deficiency in rats. Nutrients. 2014;6:4974–4983.
   PubMed Web of Science ®Google Scholar
• Nazrun AS, Norazlina M, Norliza M, et al. The anti-inflammatory role of vitamin E in prevention of osteoporosis. Adv Pharmacol Sci. 2012;2012:142702.
   PubMedGoogle Scholar
• Abdul-Majeed S, Mohamed N, Soelaiman IN. The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy. Life Sci. 2015;125:42–48.
   PubMed Web of Science ®Google Scholar
• McIntyre BS, Briski KP, Gapor A, et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med. 2000;224:292–301.
   PubMed Web of Science ®Google Scholar
• Shibata A, Nakagawa K, Sookwong P, et al. Delta-Tocotrienol suppresses VEGF induced angiogenesis whereas alpha-tocopherol does not. J Agric Food Chem. 2009;57:8696–8704.
   PubMed Web of Science ®Google Scholar
• Sugahara R, Sato A, Uchida A, et al. Annatto tocotrienol induces a cytotoxic effect on human prostate cancer PC3 cells via the simultaneous inhibition of Src and Stat3. J Nutr Sci Vitaminol (Tokyo). 2015;61:497–501.
   PubMed Web of Science ®Google Scholar
• Levy JB, Schindler C, Raz R, et al. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology. 1996;137:1159–1165.
   PubMed Web of Science ®Google Scholar
• Mikami Y, Asano M, Honda MJ, et al. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol. 2010;223:123–133.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Nomura S, Hanzawa F. Vitamin E regulates signal transduction via modification of plasma membrane structure: is this a real mechanism for the beyond antioxidant action of vitamin E? Vitamins. 2015;89:540–542.
   Google Scholar
• Davis S, Davis BM, Richens JL, et al. Alpha-tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein. J Lipid Res. 2015;56:1543–1550.
   PubMed Web of Science ®Google Scholar
• Lemaire-Ewing S, Desrumaux C, Néel D, et al. Vitamin E transport, membrane incorporation and cell metabolism: is alpha-tocopherol in lipid rafts an oar in the lifeboat? Mol Nutr Food Res. 2010;54:631–640.
   PubMed Web of Science ®Google Scholar
• van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350:2033–2041.
   PubMed Web of Science ®Google Scholar
• Vrtačnik P, Marc J, Ostanek B. Epigenetic mechanisms in bone. Clin Chem Lab Med. 2014;52:589–608.
   PubMed Web of Science ®Google Scholar
• Sato A, Ueno H, Fusegi M, et al. A succinate ether derivative of tocotrienol enhances Dickkopf-1 gene expression through epigenetic alterations in malignant mesothelioma cells. Pharmacology. 2018;102:26–36.
   PubMed Web of Science ®Google Scholar
• Peh HY, Tan WS, Liao W, et al. Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther. 2016;162:152–169.
   PubMed Web of Science ®Google Scholar